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Objective: The 10 m modified shuttle walking test
(MSWT) is recommended to determine the functional
capacity in older individuals and for patients entering
cardiac rehabilitation. Participants are required to
negotiate around cones set 1 m from the end markers.
However, consistent comments indicate that for some
individuals manoeuvring around the cones can be
quite difficult. Therefore, the objective of this study
was to explore differences within and between non-
cardiac and postmyocardial infarction (MI) males
during MSWT with and without the cones.
Design: Comparative study.
Participants: 20 post-MI (64.8±6.6, range
51–74 years) and 20 non-cardiac male controls
(64.1±5.7, range 52–74 years) participated.
Methods: Participants performed MSWT with and
without cones. Throughout, the participants expired
air, and the heart rate (bpm) (HR) and ratings of
perceived exertion (RPE) were measured. Participant
protocol preference was recorded verbatim.
Results: One-way analysis of variance found no
significant difference in VO2 peak (cones 20.4±5.1 vs no-
cones 21.9±4.8 ml/kg/min, p=0.197) or distance ambulated
(cones 631.8±132.9 m vs no-cones 662.4±164.1 m,
p=0.371) between protocols or groups. Analysis comparing
lines of regression showed a significant trajectory difference
in VO2 (ml/kg/min) (p<0.01) between protocols with higher
HR (p<0.01) and respiratory exchange ratio (RER, p<0.001)
values during cones. RPEs were higher for post-MIs versus
controls during both protocols (p<0.05). Post-MIs taking
β-blockers produce significantly lower HR values. The χ2
analysis found no significant difference in protocol
preference (no-cones: all n=25, 63%; post-MIs n=13, 65%;
and controls n=12, 60%).
Conclusions: Post-MIs found both protocols
subjectively harder than controls with no significant
difference in the VO2 peak. However, both groups worked
at a lesser percentage of their anaerobic threshold during
no-cones protocol as indicated by lower RER values.
Importantly, for the post-MIs, this would reduce their risk
of functional impairment. Therefore, though more
research is required, indicators at present are more
favourable for the use of the no-cones with post-MIs.
INTRODUCTION
It is recommended that patients entering
cardiac rehabilitation (CR) should be
measured for functional capacity both before
and after exercise training intervention.1–3 In
a clinical setting, it is often not practical
and/or possible to conduct tests of maximal
oxygen uptake (VO2 max, ml/kg/min) for
reasons of time, safety, access to specialised
equipment, tester expertise and funding.
Therefore, field tests are often employed.
Field tests generally achieve measures of
peak oxygen uptake (VO2 peak, ml/kg/min)
rather than VO2 max. VO2 peak usually coin-
cides with onset of symptoms of fatigue, such
as breathlessness and/or leg fatigue, and/or
possible angina symptoms. This measure of
functional capacity is useful in establishing
ARTICLE SUMMARY
Article focus
▪ The aim of the study was to explore whether
removing the cones at each end of the 10 m
modified shuttle walking test (MSWT) course
resulted in any difference in participant perform-
ance and/or preference.
▪ Since MSWT is used on older and cardiac popu-
lations, the aim was also to see how these
factors might differ between- and within-groups
of male post-myocardial infarction patients and
non-cardiac controls.
Key messages
▪ Post-myocardial infarctions (MIs) found both
protocols subjectively harder than the non-
cardiac male controls by reporting higher ratings
of perceived exertion values.
▪ Irrespective of group, participants worked at a
lower percentage of their anaerobic threshold
(AT) during the no-cones protocol with no sig-
nificant effect on the VO2 peak.
▪ Most significantly, for post-MIs, since there was
no significant difference in the VO2 peak between
the protocols and AT was reached at a later stage
during the no-cones protocol, this would be of
benefit to the post-MIs by reducing their risk of
any functional impairment without altering the
overall end result of the test.
▪ Although there have been some interesting find-
ings from this study, further research is still
required before the no-cones protocol can be
reliably employed.
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benchmark values of fitness and/or onset of ischaemic
threshold. During this assessment, the exercise threshold
achieved reflects a patient’s risk category4; future health
prediction,5 6 is used in establishing appropriate exercise
prescription intensity levels, progression within an exer-
cise programme and as an outcome measure.7 The
incremental modified shuttle walking test (MSWT), ori-
ginally developed for chronic obstructive pulmonary
disease patients,8 is now recommended for older and
symptomatic individuals, such as cardiac patients,1 3
including coronary artery bypass graft (CABG)
patients,9–11 those with pacemakers12 and heart
failure.13 14 Distance covered during MSWT has been
found to correlate highly with direct measures of VO2
max in CABG patients11 as well as distance walked and
VO2 peak during treadmill walking in patients with
heart failure.13 15 MSWT, therefore, offers a practical,
economic and valid assessment of the VO2 peak without
resorting to complex physiological measures of gas
analysis.11
The rationale for this present study emerged from
consistent anecdotal comments made by CR patients
about difficulty manoeuvring around the cones at each
end of the MSWT 10 m course (see figure 1). This con-
sistent comment led researchers to formally explore
whether MSWT might be better performed with the
removal of these cones and simply using tape on the
floor to denote the distances to be achieved.16
Therefore, the aim was to conduct a simple study explor-
ing comparisons between and within cardiac and non-
cardiac participants during MSWT, with and without the
cones, in order to determine whether participants better
performed and/or preferred this alternative protocol.
METHODS
Ethical approval for the study was provided by The
Faculty of Social and Applied Science Research Ethics
Committee at Canterbury Christ Church University, ref-
erence 10/SAS/045.
Participants
Post-myocardial infarction (MI) males were recruited
through the local community phase IV CR exercise
classes. The non-cardiac volunteers were recruited from
the Medway area, UK, through word of mouth and
posters placed within the University of Kent at Medway.
All volunteers were given a Participant Information
Sheet and interested individuals were asked to complete
a Health and Physical Activity (PA) Screening
Questionnaire. The post-MIs were required to be
‘uncomplicated’ and stable, be at phase IV level and be
taking standard medications (such as statin, β-blocker,
aspirin and ACE inhibitor). Potential controls were to be
free of any cardiac disease and/or event or have a
chronic medical condition and/or taking long-term
medications. All participants were required to be non-
smoking, understand the nature of the study, aged
between 50–75 years, be of similar PA level and free of
any orthopaedic limitations during exercise. Participants
that cleared the screening process were required to
provide written informed consent and have written
acknowledgement of their participation from their
General Practitioner. Participants were free to withdraw
from the study at any time without providing a reason.
Protocol
All testing was undertaken in the Exercise Rehabilitation
Gym (ERG) at the University of Kent, Medway Campus,
UK, under the supervision of a qualified British
Association of Cardiac Preventative and Rehabilitation
(BACPR) Phase IV instructor. All participants were
required to make three separate visits to the ERG. The
first was for familiarisation and the latter two for the
actual data collection. While wearing the testing equip-
ment, each participant was individually familiarised to
both test protocols.11 The order was determined by com-
puter randomisation. To ensure that participants were
competent with both protocols, they went to around
halfway and not to fatigue (reaching no more than level
7) with a break of around 8 min between each protocol.
The latter two tests were for actual data collection and
wherever possible, tests were performed at a similar time
of day to control for circadian variation.17
Pretest procedures and familiarisation
Prior to each test, including familiarisation, each partici-
pant was seated and completed a Pretest Screening
Form to ensure that on each testing occasion they were
able and well enough to perform the test and had
adhered to the pretest criteria. During the 24 h preced-
ing assessments, participants were required not to under-
take moderate to vigorous PA/exercise or consume
alcohol, nor to eat and/or consume caffeine during the
preceding 2 h; drinking water was permitted; where rele-
vant, participants were instructed to take their medica-
tions as usual.
Following satisfactory pretest screening, each partici-
pant was first measured for height and body mass using
a stadiometer (Seca 220, Hamburg, Germany) and clin-
ical scales (Seca 710, Hamburg, Germany), respectively.
The participant then sat for 5 min and was measured for
pre-exercise resting blood pressure (BP), using a stetho-
scope and sphygmomanometer (Yamasu Mercurial
Sphygmomanometer 605P, Kenzmedico Co. Ltd, Japan),
and heart rate (HR) using a Polar S810 HR monitor
(Polar Electro Oy, Kempele, Finland). If no additional
or acute physiological abnormalities were detected, par-
ticipants proceeded to either MSWT protocol. Prior to
each test, each participant was fitted with a face mask
covering the nose and mouth (Hans Rudolph,
Germany) connected to a portable gas analyser
(Cosmed K4b2, Roma, Italy) to measure and record
expired air parameters during the test.
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MSWT
The MSWT environment was well lit and ventilated, with
a non-slippery flat floor. The 10 m course was marked
out on the floor using masking tape and orange cones
(for the cones, protocol only) (figure 1 and table 1).
During both MSWT protocols, participants were exter-
nally paced by prerecorded bleeps emitted as an audible
signal played from a CD player. The timing of the bleeps
indicate walking pace and participants were required to
reach the 1 m mark at the end of the 10 m course in
time to each bleep. The test started with a slower speed
and fewer shuttles. The starting pace was 0.5 m/s and
each level was 1 min. After each minute, the speed
increased by 0.17 m/s, indicated by a treble bleep result-
ing in an increase in the number of shuttles per minute
(table 1). At the end of each level, an enlarged A3 6–20
rating of perceived exertion (RPE) scale18 was shown to
each participant to gain their subjective feelings of exer-
tion. The test was terminated if patients felt too breath-
less and/or fatigued to continue, showed signs of
physical injury and/or distress (as indicated by measures
of HR, respiratory exchange ratio (RER) and RPE) and/
or no longer wished to continue or failed to reach
within 1 m of the end marker on two consecutive
occasions. Verbal indication was given by the researcher
if the participant had not reached the 9 m marker on
time, providing the participant an opportunity to catch
up. Once the test was completed, the total distance
walked and end RPE were recorded. After removal of
the mask and portable VO2 analyser, while HR was still
being monitored, participants performed a 10 min
walking cool-down to reduce the risk of an adverse
event. Post-exercise HR and BP were measured before
participants left the test environment to ensure that
these returned to pre-exercise levels. At this point and
after the final MSWT test, each participant was asked
which of the two protocols they preferred and to
provide a short reason why. Responses were recorded
verbatim.
Data analysis
Statistical analysis was carried out using the Minitab stat-
istical package (V.16), with a 5% level of significance
and variability within a distribution of 1 SD (mean±SD).
Greater VO2 peak measures are strongly linked to
reduced mortality and morbidity,19 and in the prognosis
of cardiac patients.20 Therefore, participant numbers at
5% α and 90% power were based on a mean difference
in the VO2 peak of 2.5±3.0(ml/kg/min) between proto-
cols, which required n=17 participants to perform each
protocol. To account for attrition, n=20 participants
were recruited to each group. Therefore, any significant
difference between protocols in this factor was import-
ant in determining the tests’ ability to predict future
health status.
Inter- and intra-group differences were compared by
one-way analysis of variance. Analysis comparing two
lines of regression was employed to determine the differ-
ence between the two MSWT protocols and between
groups in VO2 (ml/kg/min), HR (bpm), RER and RPE.
Pearson’s Product Moment correlation and multiple
regression analyses were employed to determine rela-
tionships between factors. Non-parametric alternatives
were employed where data failed to be normally distribu-
ted. The χ2 test was used to compare differences in
nominal data.








1 1.1 1.8 1–3
2 1.5 2.4 4–7
3 1.9 3.1 8–12
4 2.3 3.7 13–18
5 2.6 4.2 19–25
6 3.0 4.8 26–33
7 3.4 5.5 34–42
8 3.8 6.1 43–52
9 4.2 6.8 53–63
10 4.5 7.2 64–75
11 4.9 7.9 76–88
12 5.3 8.5 89–102
MSWT,modified shuttle walking test.
Figure 1 Layout of the modified
shuttle walking test.
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RESULTS
Participant characteristics
Post-MIs and controls were matched for age and height,
but post-MIs possessed significantly greater body mass (kg)
and subsequent BMI than controls, with both groups
within the overweight category (table 2).21 Post-MIs were
tested 4.7±3.22 years post-event. Of the cardiovascular
disease (CVD) risk factors, ‘family history of CVD’, high
cholesterol, diabetes, hypertension and obesity, post-MIs
possessed a total of n=18 and controls n=11.
Medications
Analysis showed that post-MIs taking β-blockers had sig-
nificantly reduced resting HR (bpm) (β-blockers n=19,
57.7±7.0 vs n=21, 70.8±14.7 bpm, F=25.04, p<0.001) and
lower HR (bpm) during both protocols (see section
post-MIs vs controls). Those post-MIs taking β-blockers
were also taking statins, and therefore statins showed a
similar statistical effect. Too few of the other medications
had a statistically significant effect on any of the mea-
sured variables.
Results not differentiated by group
Cones vs no-cones
The order in which the participants performed each
protocol had no significant effect upon any of the mea-
sured variables. Although the mean distance during
no-cones was 30 m further compared with cones, the dif-
ference was not significant (cones 631.8±132.9 vs
no-cones 662.4±164.1 m, F=0.81, p=0.371). Furthermore,
even though a greater number of the participants
(n=25, 63%) preferred no-cones compared with cones
(n=15, 37%), this too was not significantly different.
Preference had no significant effect on the distance
ambulated for either protocol (F=0.87, p=0.354). Typical
comments given by those participants who preferred
no-cones related to ease of turning and perception of
not having to walk as far. Examples were: ‘Difficult to
manoeuvre around cone’, ‘Don’t have to walk as far and
easier to turn’, ‘Not so far to go on turn; easier to just
turn’, ‘Can walk straighter and it saves a foot at each
end’, suggesting that some participants perceived they
did not have to walk as far. The main comments from
those who preferred the cones indicated that they liked
having the cones as a target to aim for, and found the
turning easier. Analysis also showed that body mass,
height and BMI did not significantly (p>0.05) influence
preference or performance. However, those who pre-
ferred the no-cones were significantly younger (cones
n=15, 66.1±6.9 vs no-cones n=25, 63.4±5.4 years, F=3.94,
p=0.05). The negative correlation between age and dis-
tance ambulated (R=−0.491, p<0.001) indicated that
younger participants walked further, regardless of the
group they were in. Not all participants achieved all
levels during MSWT (table 3).
Table 2 Participant characteristics mean±SD (range)
Characteristics Post-MIs, n=20 Controls n=20
Age (years) 64.8±6.6 (51–74) 64.1±5.7 (52–74)
Height (cm) 175.9±5.8 (165–185) 175.5±6.7 (164–186)
Body mass (kg) 87.7±13.2 (64–111)* 82.0±11.9 (62–102)
BMI (kg/m2) 28.3±3.8 (20.5–35.5)* 26.6±3.0 (21.6–31.9)
Pre-exercise resting
SBP (mm Hg) 122.4±19.0 (100–180)* 133.6±15.7 (106–170)
Cones 124.8±16.1 (98–158) 133.1±15.7 (110–170)
No-cones
Pre-exercise resting
DBP (mm Hg) 79.8±8.7 (64–96) 85.1±10.0 (70–110)
Cones 79±10.3 (60–100) 84.2±8.0 (70–98)
No-cones
Pre-exercise resting
HR (bpm) 57.8±7.6 (36.6–69.1)† 74.1±17.2 (45.4–109.8)
Cones 57.5±6.2 (40.8–70.1)† 68.8±11.8 (44.0–90.9)
No-cones
Weekly PA
30 min sessions at moderate intensity 4.3±1.8 (1–7)† 3.0±2.3 (0–7)
20 min sessions at vigorous intensity 2.4±2.0 (0–6) 1.7±1.5 (0–5)
*Statistically significantly different from controls at p<0.05.
†Statistically significantly different from controls at p<0.01.
BMI, body mass index; DBP, diastolic blood pressure; HR, heart rate; MI: myocardial infarction; PA, physical activity; SBP, systolic blood
pressure.
Table 3 Level achieved by participants during MSWT for
different protocols
Level 1–7 8 9 10 11 12
Cones 40 40 30 20 10 1
No-cones 40 38 31 21 12 4
MSWT,modified shuttle walking test.
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A significant difference was found in the VO2 (ml/kg/
min) versus MSWT-level relationship (F=10.26 p<0.01,
figure 2) (level 12 excluded as too few numbers); HR
(bpm) (levels 1–10) (F=7.61 p<0.01, figure 3) and RER
(levels 1–10) (F=41.11, p<0.001, figure 4) versus
MSWT-level relationships were consistently lower than
the no-cones protocol. There were no significant
differences in the RPE or VO2 peak (cones, 20.4±5.1 vs
no-cones 21.9±4.8 ml/kg/min, F=1.69, p=0.197).
Post-myocardial infarctions
Although post-MIs walked a mean of 44.4 m further
during the no-cones, this was not statistically significant
(cones, 613.0±114.0 vs no-cones, 657.9±167.8 m, F=0.79,
p=0.380). There was no significant difference in the VO2
peak between protocols (cones, 19.3±4.9 vs no-cones,
21.1±5.0 ml/kg/min, F=1.29, p=0.264). VO2 (ml/kg/min)
and RER versus MSWT-level relationship were significantly
higher and lower for the no-cones (F=10.26 p<0.01; F=9.38
p=0.002, figure 5 and 6), respectively. However, HR (bpm)
and RPE were not significantly different. Although
13 (65%) post-MIs preferred no-cones versus 7 (35%)
cones, this was not significantly different. Not all post-MIs
achieved all levels during MSWT (table 4).
Controls
The controls walked 15.7 m further during the no-cones
compared with the cones, which was not statistically sig-
nificant (cones, 651.1±120.8 vs no-cones 666.8±164.8 m,
F=0.11, p=0.738). There was no significant differences in
the VO2 peak (cones, 21.3±5.2 vs no-cones, 22.7±4.6 ml/
kg/min, F=0.51, p=0.478), or VO2 (ml/kg/min) and
RPE versus MSWT-level relationship between protocols.
However, the HR (bpm) and RER relationships were sig-
nificantly higher during the cones (F=11.34, p<0.001,
figure 7; F=35.93, p<0.001, figure 8, respectively).
Despite the majority of the controls preferring the
no-cones (cones n=8, 40% and no-cones n=12, 60%),
Figure 2 The VO2 (ml/kg/min) versus modified shuttle
walking test-level relationship for the different protocol.
Figure 3 The heart rate (bpm) versus modified shuttle
walking test-level relationship for the protocols.
Figure 4 Respiratory exchange ratio versus modified shuttle
walking test-level relationship for the different protocols.
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this again was not significantly different. Not all controls
achieved all levels during MSWT (table 5).
Post-MIs vs controls
Cones
Although the controls walked a mean of 37.6 m further
than post-MIs, this was not statistically significant
(post-MIs, 613.5±144.0 vs controls, 651.1±120.8 m,
F=0.77, p=0.385). Eight controls and seven post-MIs pre-
ferred the cones, which too was not significantly differ-
ent. There was no significant difference in the VO2 (ml/
kg/min) or RER versus MSWT-level relationships
between groups. However, HR (bpm) was significantly
lower for post-MIs (n=19 taking β-blockers) versus con-
trols (F=72.2, p<0.001; none were taking β-blockers).
RPE versus MSWT-level relationship values were signifi-
cantly higher for post-MIs versus controls (F=4.78,
p=0.029, figure 9).
No-cones
Controls walked a mean of 8.9 m further than post-MIs
during the no cones, which was not statistically significant
(post-MIs, 657.9±167.8 vs controls, 666.8±164.8 m, F=0.03,
p=0.869). Twelve controls and 13 post-MIs preferred the
no-cones, which too was not significantly different. There
was no significant difference in the VO2 (ml/kg/min)
versus MSWT-level relationship between groups. The HR
(bpm) versus MSWT-level relationship was significantly
lower in post-MIs versus controls (F=51.24, p<0.001) and
significantly higher for RER and RPE (F=23.51 p<0.001,
figure 10; F=4.78, p=0.029, figure 11, respectively).
Extra data are available by emailing the first author.
DISCUSSION
Comments collected from those participants as to why
they preferred the no-cones suggested that some partici-
pants perceived they did not have to walk as far, as they
did not have to manoeuvre around the cones, which
they found difficult to negotiate. Those who preferred
the cones generally liked the cones as a target to aim for
and found the turning easier. Anthropometric factors
such as height and body mass, which might be expected
to have some mechanical influence, were found not to
have any statistically significant effect upon preference.
Analysis did, however, reveal that the younger partici-
pants, regardless of group, preferred the no-cones.
These participants tended to walk further, subsequently
reaching faster walking speeds. The turning technique
employed in the no-cones is more representative of a
‘touch and turn’, where participants touched the end
tape with their foot and turned, whereas the cones
requires participants to negotiate around the end cone
within the 1 m space between the tape at the end
(figure 1). At higher walking speeds, the latter might
make turning difficult and partly explain why the
Figure 6 Post-myocardial infarctions respiratory exchange
ratio versus modified shuttle walking test-level relationship for
the different protocols.
Table 4 Level achieved by post-MIs during MSWT for
different protocols
Level 1–7 8 9 10 11 12
Cones 20 20 13 7 4 0
No-cones 20 18 15 9 5 2
MI, myocardial infarction; MSWT,modified shuttle walking test.
Figure 5 Post-myocardial infarctions VO2 (ml/kg/min) versus
modified shuttle walking test-level relationship for the different
protocols.
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younger faster walkers preferred the no-cones. Although
the majority of participants preferred the no-cones (all
n=25, 63%; post-MIs n=13, 65%; controls n=12, 60%),
this was not statistically significant. Retrospective second-
ary power analysis for nominal data showed that a major-
ity of 68% were required to achieve statistical
significance at p<0.05. Since preference percentage was
not far from this figure, it is likely that this factor was
underpowered and would be worth exploring further in
a future study.
The relationship between VO2 peak with mortality and
morbidity,19 and prognosis in cardiac patients20 is an
important factor in determining an individual’s health
status. Since there was no significant difference between
the two protocols in the VO2 peak, this would suggest
that the no-cones is as effective at determining health
outcomes as the current cones protocol.
HR values (for those participants not taking
β-blockers) and RER values were significantly higher
during the cones, indicating that participants worked at
a higher percentage of their anaerobic threshold
(AT).22 Although there is debate about the best indirect
marker of AT, a recent study by Solberg et al,23 looking
at a range of VO2 parameters, found the marker of
RER ≥ 1.0 to be a reliable indicator of AT. For the cones,
participants reached AT (RER≥ 1.0) at lower walking
speeds. This differed between protocols by around one
MSWT-level (figures 4, 6 and 8) and between groups by
around 2 levels (figure 11). While this may not be too
much of an issue for non-cardiac populations, for the
post-MIs this is of importance. There is a potential
Figure 7 Controls heart rate (bpm) versus modified shuttle
walking test-level relationship for the different protocols.
Figure 8 Controls respiratory exchange ratio versus modified
shuttle walking test-level relationship for the different
protocols.
Table 5 Level achieved by controls during MSWT for
different protocols
Level 1–7 8 9 10 11 12
Cones 20 20 17 13 6 1
No-cones 20 20 16 12 7 2
MSWT, modified shuttle walking test.
Figure 9 Ratings of perceived exertion versus modified
shuttle walking test-level relationship between post-myocardial
infarctions and controls during the cones protocol.
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health risk for cardiac patients working at the higher
end of their AT as this can result in functional impair-
ment and possible ischaemia.24 Therefore, in this
context, keeping below AT without affecting in the VO2
peak would be beneficial for post-MIs. Interestingly,
values of RPE did not differ between protocols for the
post-MIs, who did report higher RPE values than con-
trols, indicating that they found both protocols more
difficult.
Despite no statistically significant differences being
observed in the VO2 peak between protocols or groups,
there was a significant difference in the VO2 versus
MSWT shuttle-level (walking speed) relationship
between the protocols before the groups were differen-
tiated. Secondary analysis revealed that this was due to
the steepness of the trajectory of the lines of regression
rather than the difference in the VO2 (ml/kg/min)
values at each level per se. However, during the
no-cones, it was the post-MIs who consistently showed a
higher VO2 versus MSWT shuttle-level (walking speed)
relationship, which was not seen in the controls.
Interestingly, Roberts et al25 observed that during tread-
mill testing, healthy and coronary artery disease (CAD)
patients, at any given workload below AT, produced
similar VO2 values. Yet, at workloads beyond AT, CAD
patients produced lower VO2 values than their healthy
controls. This, however, was not observed between the
post-MIs and controls of this study.
HR values were significantly lower at pre-test rest and
during both protocols for post-MIs compared with con-
trols, which was most likely due to the β-blockers.
Nineteen (95%) post-MIs were taking this drug, which is
standard prescription post-MI.26 This drug not only
alters cardiorespiratory response (slower HR) but can
also slow down oxygen kinetics.27 28 Evidence indicates
that β-blockers can reduce skeletal muscle blood flow
and thus increase general fatigue.29–32 The very same
participants that took β-blockers were also taking statins,
which produced a similar statistical result. High doses of
statins can lead to muscle myopathy and interfere with
fatty acid oxidation, producing greater oxidation of car-
bohydrates.33 Given that the post-MIs on statins were on
relatively low doses (40 mg), it is unlikely that the statins
had any such effect. However, similar depressive effects
on lipolysis have been found from β-blockers.34 35 These
factors might partly explain why post-MIs reported
higher RPE values during both protocols, though there
was no difference in RER or VO2 values between groups.
It has been reported that β-blockers do not affect RPE
in clinical groups36–38 and do not tend to influence
unless exercise is longer than 60 min and/or at an inten-
sity higher than 65% VO2 max.
30 31 This exercise inten-
sity would most likely have been achieved during the
latter stages of either MSWT protocol and might there-
fore explain the heteroscedasticity observed in RPE
between groups (see figure 6).
The current cones version of MSWT has been shown
to correlate highly with peak VO2 during treadmill tests
in a range of different cardiac11 39 40 and respiratory
populations.41 In our previous work,16 a group of non-
cardiac males (n=19, 64.6±7.5 years) performed both
MSWT without the cones and a treadmill test of the
same protocol. Here too, the limits of agreement ana-
lysis42 showed acceptability between the treadmill and
no-cones MSWT in VO2 (ml/kg
−1/min) (mean differ-
ence –1.1±8.8 (1.96 SD), CI 7.7 to 9.9), reflected by a
strong correlation (R=0.88, R2=0.48, p<0.001). The
Figure 10 Respiratory exchange ratio versus modified
shuttle walking test-level relationship between post-myocardial
infarctions and controls during the no-cones protocol.
Figure 11 Ratings of perceived exertion versus modified
shuttle walking test-level relationship between post-myocardial
infarctions and controls during the no-cones protocol.
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findings therefore indicate that the no-cones version of
MSWT correlates as strongly as the cones version with
treadmill tests for non-cardiac participants. The next
stage would obviously be to repeat this in a group of
cardiac patients. Additionally, although the learning and
order effect had been accounted for within this study,
test–retest repeatability was not. In order for the
no-cones version to be reliably employed, both these
factors require to be determined in future research.
In conclusion, it is clear that additional research is
required before the no-cones version of MSWT can be
reliably adopted. However, the findings of this study indi-
cate that despite post-MIs finding both protocols subject-
ively harder than the non-cardiac controls, both groups
work at a lower percentage of their AT during the
no-cones protocol with no significant effect upon the
VO2 peak. Therefore, in the context of CR, the no-cones
protocol would allow the patient to perform MSWT with
less risk of functional impairment.
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